Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry-Reference-Cited by-同舟云学术

Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry

Published:2014-04-29 Issue:3 Volume:33 Page:147-151
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematol Oncol

Author:

Biasoli Irene¹,Cesaretti Marina²,Bellei Monica²,Maiorana Antonino²,Bonacorsi Goretta³,Quaresima Micol²,Salati Massimiliano²,Federico Massimo²,Luminari Stefano²

Affiliation:

1. Department of Medicine; University Hospital and School of Medicine, Universidade Federal do Rio de Janeiro; Rio de Janeiro Brazil

2. Dipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica; Università di Modena e Reggio Emilia; Modena Italy

3. Azienda policlinico ospedaliera di Modena; Modena Italy

Funder

FAPERJ

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2144/fullpdf

Reference16 articles.

1. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research;Jaffe;Hematology Am Soc Hematol Educ Program,2009

2. Peripheral T-cell lymphoma not otherwise specified;Savage;Crit Rev Oncol Hematol,2011

3. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management;Armitage;Am J Hematol,2012

4. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma);Dearden;Br J Haematol,2011

5. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study;Gallamini;Blood,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peripheral T-cell lymphoma: From biology to practice to the future;Cancer Treatment Reviews;2024-09

2. The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas;Blood Advances;2024-06-28

3. Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma;Journal of Hematology & Oncology;2024-06-01

4. Antitumor activity and safety of camrelizumab combined with apatinib in patients with relapsed or refractory peripheral T-cell lymphoma: An open-label, multicenter, phase II study;Frontiers in Immunology;2023-04-04

5. Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma;Cancers;2023-01-18